Alliance Dermatology

CLIA Laboratory Citation Details

3
Total Citations
10
Total Deficiencyies
8
Unique D-Tags
CMS Certification Number 03D2017722
Address 313 S Beeline Hwy, Payson, AZ, 85541
City Payson
State AZ
Zip Code85541
Phone(928) 472-7107

Citation History (3 surveys)

Survey - January 13, 2026

Survey Type: Standard

Survey Event ID: XAXR11

Deficiency Tags: D5209 D5291 D5217 D5401 D5805

Summary:

Summary Statement of Deficiencies D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on review of personnel policies and interview with the facility personnel on 1 /13/26 at 11:59 AM, the laboratory failed to follow established policies and procedures to assess the competency of one out of three testing personnel (TP-1) who perform the microscopic interpretation of Mohs specimens. Findings include: 1. The laboratory performs the microscopic interpretation of Mohs specimens in the subspecialty of Histopathology, with an approximate annual test volume of 1,200. 2. The CMS-209, Laboratory Personnel Form listed 3 testing personnel who read and interpret slides. 3. The laboratory policy reviewed during the survey states, "Ensure accuracy verification is completed for everyone who reads/interprets slides. The accuracy verification can be used as evidence of annual competency for these individuals." 4. The laboratory failed to perform and document annual competency for TP-1 during 2025, as evidenced by the lack of accuracy verification records specific to TP-1 during 2025. 5. The facility personnel interviewed on 1/13/26 at 11:59 AM confirmed the laboratory failed to follow the established personnel competency policy indicated above to assess the competency of TP-1 during 2025. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- This STANDARD is not met as evidenced by: Based on lack of accuracy verification documentation for the microscopic interpretation of Frozen Biopsy specimens and interview with the facility personnel on 1/13/26 at 11:50 AM, the laboratory failed to verify the accuracy of Frozen Biopsy testing performed under the subspecialty of Histopathology at least twice annually during 2025. Findings include: 1. No documentation was presented for review to indicate the laboratory verified the accuracy of the microscopic interpretation of Frozen Biopsy specimens at least twice annually during 2025. 2. The facility personnel interviewed on 1/13/26 at 11:50 AM confirmed the laboratory failed to verify the accuracy of histopathology testing at least twice annually during 2025. 3. The laboratory performed 8 frozen biopsies in 2025. D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on lack of established policies and procedures for review and interview with the facility personnel on 1/13/26 at 11:55 AM, the laboratory failed to establish policies and procedures for the accuracy verification process of Mohs and Frozen Biopsy specimens tested by the laboratory. Findings include: 1. The laboratory performs the microscopic interpretation of Mohs and Frozen Biopsy specimens in the subspecialty of Histopathology with a reported annual test volume of 1,200. 2. No documentation was presented for review to indicate the laboratory established policies and procedures related to the accuracy verification process for Mohs and Frozen Biopsy testing, including but not limited to, the frequency of the review, number of cases reviewed, individual or laboratory performing the review and a remedial action plan in the event of a noted discrepancy. 3. The facilty personnel interviewed on 1/13 /26 at 11:59 AM confirmed the laboratory failed to provide evidence of an established policy and procedure specific to the verification of accuracy process for the microscopic interpretation of Mohs and Frozen Biopsy specimens. D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) (a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on review of test procedures on 1/13/26 at 11:45 AM for testing performed in the subspecialty of Histopathology and interview with the facility personnel, the laboratory failed to establish a written test procedure for Frozen Section Biopsy testing. Findings include: 1. The laboratory performs testing in the subspecialty of Histopathology with a reported annual test volume of 1,200. 2. No evidence was -- 2 of 3 -- presented for review during the survey conducted on 1/13/26 to indicate the laboratory established a written test procedure for Frozen Section Biopsy testing. 3. The facility personnel interviewed on 1/13/26 at 11:45 AM confirmed the laboratory failed to establish a written test procedure for Frozen Biopsy testing. 4. The laboratory performed the microscopic interpretation of 8 Frozen Biopsy specimens in 2025. D5805 TEST REPORT CFR(s): 493.1291(c) (c) The test report must indicate the following: (c)(1) For positive patient identification, either the patient's name and identification number, or a unique patient identifier and identification number. (c)(2) The name and address of the laboratory location where the test was performed. (c)(3) The test report date. (c)(4) The test performed. (c)(5) Specimen source, when appropriate. (c)(6) The test result and, if applicable, the units of measurement or interpretation, or both. (c)(7) Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability. This STANDARD is not met as evidenced by: Based on review of pathology test reports for Frozen Biopsy interpretations and interview with the facility personnel on 1/13/26 at 11:40 AM, the laboratory failed to include the test report date, gross description and two patient identifiers on 1 out of 1 frozen biopsy test reports reviewed during the survey. Findings include: 1. The laboratory performs the diagnostic interpretation of Frozen Biopsy specimens in the subspecialty of Histopathology, and performed 8 Frozen Biopsies in 2025. 2. One out of one frozen biopsy test reports reviewed during the survey failed to include the test report date, the gross description and failed to include at least two positive patient identifiers. 3. The facility personnel interviewed on 1/13/26 at 11:40 AM acknowledged that the test report date, gross description and two positive patient identifiers were missing from the frozen biopsy test report reviewed during the survey. -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 4, 2024

Survey Type: Standard

Survey Event ID: X0LO11

Deficiency Tags: D5791 D5473

Summary:

Summary Statement of Deficiencies D5473 CONTROL PROCEDURES CFR(s): 493.1256(e)(2)(g) (e) For reagent, media, and supply checks, the laboratory must do the following: (e) (2) Each day of use (unless otherwise specified in this subpart), test staining materials for intended reactivity to ensure predictable staining characteristics. Control materials for both positive and negative reactivity must be included, as appropriate. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on lack of Quality Control (QC) documentation for one out of four testing dates reviewed during the survey and interview with the facility personnel, the laboratory failed to document the acceptability of Hematoxylin & Eosin (H&E) staining materials each day of use, for intended reactivity to ensure predictable staining characteristics. Findings include: 1. No documentation of the H&E stain acceptability was presented for review for Mohs testing that occurred on October 19, 2023. 2. A total of 9 Mohs cases were performed on the date indicated above. 3. The facility personnel interviewed on September 04, 2024 at 11:50 AM confirmed the laboratory failed to document the H&E stain acceptability on the testing date indicated above, for intended reactivity to ensure predictable staining characteristics. D5791 ANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1289(a)(c) (a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the analytic systems specified in 493.1251 through 493.1283. (c) The laboratory must document all analytic systems assessment activities. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- This STANDARD is not met as evidenced by: Based on lack of quality assessment (QA) documentation from 2023 and interview with the facility personnel, the laboratory failed to follow established QA policies and procedures to monitor, assess, and when indicated, correct problems identified in the analytic systems specified in 493.1251 through 493.1283. Findings include: 1. It is the practice of the laboratory to perform an annual review of the patient testing process and document the review on a form titled, "Quality Assessment Review Form and Checklist". 2. No QA documentation was provided for review from 2023. 3. The facility personnel interviewed on 09/04/24 at 12:10 PM confirmed the laboratory failed to provide documentation of an annual QA review from 2023. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 20, 2019

Survey Type: Standard

Survey Event ID: 6C7911

Deficiency Tags: D5473 D5217 D5781

Summary:

Summary Statement of Deficiencies D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on lack of accuracy verification documentation for review and interview with the facility personnel, the laboratory failed to verify the accuracy of testing performed under the sub-specialty of Histopathology at least twice annually during 2018. Findings include: 1. No documentation was presented for review during the survey to indicate that the laboratory verified the accuracy of Mohs testing at least twice annually during 2018. 2. The facility personnel confirmed that the laboratory failed to verify the accuracy of Mohs testing at least twice annually during 2018. D5473 CONTROL PROCEDURES CFR(s): 493.1256(e)(2)(g) (e) For reagent, media, and supply checks, the laboratory must do the following: (e) (2) Each day of use (unless otherwise specified in this subpart), test staining materials for intended reactivity to ensure predictable staining characteristics. Control materials for both positive and negative reactivity must be included, as appropriate. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on lack of Quality Control (QC) documentation and interview with the facility personnel, the laboratory failed to document the acceptability of staining materials used for testing performed in the sub-specialty of histopathology. Findings include: 1. The laboratory performs patient testing under the sub-specialty of Histopathology Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- with an approximate annual test volume of 3,247. 2. No documentation of the H & E stain acceptability was presented for review for testing that occurred on 06/25/2019. The number of patients tested that date could not be determined at the time of the survey. 3. The facility personnel confirmed that the laboratory failed to document the H & E stain acceptability on the date indicated above. D5781

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access